SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-22-041948
Filing Date
2022-02-14
Accepted
2022-02-14 16:39:16
Documents
2
Group Members
CHART WESTCOTTNEIL SHAHRESTANI

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d294483dsc13ga.htm SC 13G/A 78181
2 EX-99.1 d294483dex991.htm EX-99.1 4761
  Complete submission text file 0001193125-22-041948.txt   84715
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Subject) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88372 | Film No.: 22633362
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 100 CRESCENT COURT SUITE 1620 DALLAS TX 75201
Business Address 100 CRESCENT COURT SUITE 1620 DALLAS TX 75201 214-364-2883
Ikarian Capital, LLC (Filed by) CIK: 0001778253 (see all company filings)

IRS No.: 473466768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A